Evernorth Launches AI Pharmacy Forward
Analysis based on 12 articles · First reported Jul 01, 2026 · Last updated Jul 02, 2026
The launch of Pharmacy Forward by The Cigna Group, a division of The Cigna Group, is expected to positively impact the healthcare and pharmaceutical industries by improving specialty care delivery through AI. This innovation could lead to increased efficiency, better patient outcomes, and potentially higher revenue for The Cigna Group, making its stock more attractive to investors.
The Cigna Group, the health services division of The Cigna Group, launched Pharmacy Forward, a new AI-powered program aimed at enhancing specialty pharmacy care. The program, backed by a $100 million investment through 2028, will initially be implemented at Cigna — Accredo Specialty Pharmacy. Pharmacy Forward leverages AI across clinical care, prescription intake, administration, and medication fulfillment to streamline processes, personalize patient support, and improve medication adherence. The Cigna Group anticipates the program will generate approximately $400 million in value by the end of 2028 and plans to expand its capabilities to other pharmacies in the future. Key figures like Matt Perlberg and Katya Andresen emphasized the program's potential to reduce administrative burdens for clinicians and accelerate medication access for patients.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard